During the past decade, University of Washington Virology Research Clinic conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 13 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Washington Virology Research Clinic" #1 sponsor was "University of Washington" with 14 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials sponsored, "Genocea Biosciences, Inc." with 3 trials sponsored, "AiCuris Anti-infective Cures AG" with 2 trials sponsored and "Agenus Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Washington Virology Research Clinic" #1 collaborator was "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "CONRAD" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Washington Virology Research Clinic" are "Genital Herpes" (9 trials), "COVID-19" (6 trials), "Genital Herpes Simplex Type 2" (3 trials), "HIV Infections" (2 trials) and "Herpes Simplex" (2 trials). Many other conditions were trialed in "University of Washington Virology Research Clinic" in a lesser frequency.

Most popular intervention types in "University of Washington Virology Research Clinic" are "Drug" (24 trials), "Biological" (10 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "acyclovir" (5 trials), "Valacyclovir" (4 trials), "valacyclovir" (3 trials) and "AIC316" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Washington Virology Research Clinic" are 28 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Washington Virology Research Clinic". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in University of Washington Virology Research Clinic, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Washington Virology Research Clinic, 5 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 1 trials that are defined as “Not Applicable".